-Advertisement-
Home
Real-world data highlights faricimab’s effectiveness in patients with treatment-experienced nAMD
Retina Care 360

Real-world data highlights faricimab’s effectiveness in patients with treatment-experienced nAMD
Faricimab provides significant anatomical improvements and extends treatment intervals in treatment-experienced patients with neovascular age-related macular degeneration (nAMD), while maintaining vision and potentially reducing the treatment burden, according to results from a real-world study. The single-center retrospective study included 184 patients (215 eyes) who switched to faricimab after receiving an...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Contact Info
© 2025 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved